GROUP ONE TRADING, L.P. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is and the CUSIP is 363225952. A total of 3 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$768
+33.3%
4000.0%0.00%
Q2 2023$576
-31.4%
4000.0%0.00%
Q1 2023$840
-75.2%
400
-86.7%
0.00%
Q4 2022$3,390
-78.8%
3,000
-70.3%
0.00%
Q3 2022$16,0000.0%10,100
-17.2%
0.00%
Q2 2022$16,000
-63.6%
12,200
-55.3%
0.00%
Q1 2022$44,000
+18.9%
27,300
+52.5%
0.00%
Q4 2021$37,000
-72.8%
17,900
-48.9%
0.00%
Q3 2021$136,000
+147.3%
35,000
+104.7%
0.00%
Q2 2021$55,000
+816.7%
17,100
+557.7%
0.00%
Q1 2021$6,000
-53.8%
2,600
-55.2%
0.00%
Q4 2020$13,000
-40.9%
5,800
-30.1%
0.00%
Q3 2020$22,000
-57.7%
8,300
-50.9%
0.00%
Q2 2020$52,000
+67.7%
16,900
+6.3%
0.00%
Q1 2020$31,000
-65.9%
15,900
-50.0%
0.00%
-100.0%
Q4 2019$91,000
-28.3%
31,800
-8.1%
0.00%0.0%
Q3 2019$127,000
-10.6%
34,600
+1.2%
0.00%0.0%
Q2 2019$142,000
-68.1%
34,200
-60.7%
0.00%
-80.0%
Q1 2019$445,000
+124.7%
87,100
+50.7%
0.01%
+150.0%
Q4 2018$198,000
-80.1%
57,800
-65.2%
0.00%
-75.0%
Q3 2018$997,000
+2.4%
165,900
+8.3%
0.01%0.0%
Q2 2018$974,000
+258.1%
153,200
+167.4%
0.01%
+166.7%
Q1 2018$272,000
-56.0%
57,300
-69.0%
0.00%
-25.0%
Q4 2017$618,000
+111.6%
184,900
+34.3%
0.00%
+33.3%
Q3 2017$292,000
+13.2%
137,700
+31.3%
0.00%0.0%
Q2 2017$258,000
+732.3%
104,900
+688.7%
0.00%
Q1 2017$31,00013,3000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Citadel Advisors 14,100$71,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders